T2 Biosystems Receives BARDA Contract to Fight Antimicrobial Resistance, Shares Up More than 88%
Source: Streetwise Reports  (9/11/19)
This healthcare diagnostics stock rose more than 88% on Wednesday following the award of a BARDA contract that could be worth up to $69 million. More >

An 'Electrical Storm' of Catalysts Converge to Jump Start Sales of Eguana's Solar-Power Storage Solutions
Source: Knox Henderson for Streetwise Reports  (9/10/19)
The small-cap energy storage firm just signed a global production agreement with industry heavyweight Jabil. More >

Condolences on the Death of Barbara Moriarty
Source: Streetwise Reports  (9/10/19)
We are deeply saddened to hear of the death of Barbara Moriarty, cofounder of 321 Gold. More >

Mallinckrodt Shares Up 60% as It Announces Sale of Unit
Source: Streetwise Reports  (9/10/19)
Shares of Mallinckrodt Plc are trading more than 60% higher today on news that the company is selling its CDMO subsidiary BioVectra Inc. to H.I.G. Capital for $250 million. More >

Red Lake Explorer Keeps Making Discoveries
Source: Maurice Jackson for Streetwise Reports  (9/10/19)
Chris Taylor, CEO of Great Bear Resources, talks with Maurice Jackson of Proven and Probable about his company's exploration efforts in Canada's prolific Red Lake District. More >

Security Firm Engages House of Worship to Beta Test Threat Detection System
Source: Streetwise Reports  (9/9/19)
This is the first organization of its kind to collaborate in this regard. More >

Wounded Animals, Indeed
Source: Michael Ballanger for Streetwise Reports  (9/9/19)
Sector expert Michael Ballanger offers his observations of recent activity in the gold and silver markets. More >

Silver's Sharp Reaction Back
Source: Clive Maund for Streetwise Reports  (9/9/19)
Technical analyst Clive Maund charts silver and explains why he believes it hasn't hit a final top. More >

ACADIA Pharma's Shares Open 75% Higher on Positive Anti-Psychosis Drug Phase 3 Results
Source: Streetwise Reports  (9/9/19)
Shares of ACADIA Pharmaceuticals opened up 75% higher today after the company announced that its Phase 3 Study of pimavanserin for the treatment of dementia-related psychosis met its primary endpoint. More >

Technical Analyst: Significant Correction for Gold Has Started
Source: Clive Maund for Streetwise Reports  (9/9/19)
Technical analyst Clive Maund discusses the factors he sees pulling gold down. More >

Technology License Triggers $10 Million Milestone Payment for Biopharma
Source: Streetwise Reports  (9/9/19)
This is the first of many such potential payments under the related agreement. More >

Threat Detection Solutions Provider Buys Artificial Intelligence, Machine Learning Firm
Source: Streetwise Reports  (9/9/19)
This move is a key differentiator for future development of the Canadian company's platform. More >

Production Royalty Transaction Closes for Vancouver-Based Company
Source: Streetwise Reports  (9/9/19)
This asset is another significant addition to the firm's expanding portfolio. More >

Exploring for Copper in Major Belt in the Yukon
Source: Maurice Jackson for Streetwise Reports  (9/9/19)
Tim Johnson, CEO of Granite Creek Copper, speaks with Maurice Jackson of Proven and Probable about his company's exploration activities in the Yukon. More >

North America's 'Newest Gold Royalty Company' Gaining Recognition
Source: Streetwise Reports  (9/6/19)
This company's unique option/royalty model has caught the attention of major resource investors. More >

Analyst Raises Q3/19 Production Estimates for Texas-Based Oil & Gas Company
Source: Streetwise Reports  (9/6/19)
The revisions and the reasons for them are discussed in a ROTH Capital Partners report. More >

Texas Firm Represents 'Inexpensive Way to Buy Integration in Midstream'
Source: Streetwise Reports  (9/6/19)
The reasons this energy firm warrants a rerating are discussed in a Raymond James report. More >

With Its Val d'Or Assets, Exploration Company 'On Track to Get Serious Attention'
Source: Streetwise Reports  (9/6/19)
The recently released resource estimate and other reasons why this Canadian firm makes a premium takeout target are provided in an iA Securities report. More >

Neon Therapeutics Shares Are Flashing Brightly after Reporting Predictive Cancer Breakthrough
Source: Streetwise Reports  (9/6/19)
After announcing publication in the scientific journal Immunity that it had created a 61-fold improvement process for predicting cancer-specific antigens, Neon Therapeutics' stock has traded wildly today, up more than 46% at times on nearly 100-times average daily volume, but has since pulled back greatly. More >

Silver, Gold and Platinum Are Due a Break
Source: Bob Moriarty for Streetwise Reports  (9/5/19)
Bob Moriarty of 321 Gold explains what one indicator is showing for the precious metals. More >

First Cobalt, Last Man Standing in North American Cobalt Sector
Source: Peter Epstein for Streetwise Reports  (9/5/19)
An agreement with Glencore enabling advancement of recommissioning and expansion plans for the junior's cobalt refinery makes First Cobalt a good bet for investors, according to Peter Epstein of Epstein Research. More >

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%
Source: Streetwise Reports  (9/5/19)
Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. More >

Coverage Initiated on 'Biotech Machine'
Source: Streetwise Reports  (9/4/19)
The compelling reasons behind those descriptors are explored in a Dawson James Securities report. More >

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'
Source: Streetwise Reports  (9/4/19)
The study data and their implications are provided in a BTIG report. More >

Fiscal Year 'Reads Well' for Regenerative Medicine Company
Source: Streetwise Reports  (9/4/19)
The firm's final quarter and full-year results are reviewed in a Ladenburg Thalmann report. More >